Should ARDS be renamed diffuse alveolar damage?

B Taylor Thompson¹, Claude Guérin^{2

3}, Andrés Esteban⁴

Affiliations

¹ Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. tthompson1@partners.org.
² Reanimation Medicale, Hôpital de la Croix-Rousse, Lyon, France.
³ IMRB INSERM 955 Eq13 Créteil, Créteil, France.
⁴ Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, Getafe, Spain.

B Taylor Thompson et al. Intensive Care Med. 2016 May.

. 2016 May;42(5):653-655.

doi: 10.1007/s00134-016-4296-5. Epub 2016 Mar 14.

B Taylor Thompson¹, Claude Guérin^{2

3}, Andrés Esteban⁴

¹ Division of Pulmonary and Critical Care, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. tthompson1@partners.org.
² Reanimation Medicale, Hôpital de la Croix-Rousse, Lyon, France.
³ IMRB INSERM 955 Eq13 Créteil, Créteil, France.
⁴ Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, Getafe, Spain.

No abstract available

References